Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00619658
Other study ID # PRO07080379
Secondary ID
Status Completed
Phase N/A
First received February 8, 2008
Last updated January 27, 2016
Start date February 2008
Est. completion date August 2009

Study information

Verified date January 2016
Source University of Pittsburgh
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

To assess the feasibility of using simplified telephone follow-up to predict pregnancy expulsion after medical abortion, and if in-person follow-up is required to determine the percentage of women that will present for that follow-up.


Description:

This is a prospective trial to evaluate the feasibility of performing a telephone interview to predict if pregnancy expulsion has occurred. In those women for whom expulsion has not been predicted to have occurred, the trial will evaluate if they will present for a follow-up visit. We plan to recruit 154 women that desire a medical abortion from Magee-Womens Hospital, Planned Parenthood of Western Pennsylvania, and private offices in the surrounding area. Women who are no more than 63 days gestation will receive mifepristone 200mg and misoprostol 800mcg. Each subject will choose between two evidence-based methods of using the misoprostol: buccally 24-72 hours or vaginally 0-72 hours after mifepristone. A follow-up phone call with a clinician will occur 5-9 days after mifepristone administration. Based on clinical history, including a structured question set, the subject and the clinician will predict if expulsion occurred. If either or both feel that expulsion may not have occurred, the women will return for follow-up in the office within one week for sonographic evaluation. If they both predict that expulsion has occurred at this initial phone call follow-up, the subject will perform a urine pregnancy test at home in approximately 3 weeks. She will have a follow-up phone call after the pregnancy test to obtain the results. The subject will only have an additional visit and ultrasound examination if the urine pregnancy test is positive.

The primary outcome is the percentage of women that will be available for follow-up over the phone, and/or return visit if necessary. The secondary outcomes are to determine if a standardized set of questions of clinical history after medical abortion will be useful to predict expulsion of the pregnancy and which mode of misoprostol administration women prefer. In addition, the study will confirm if women and clinicians are accurate at predicting expulsion of the pregnancy, compare the ability of patients and clinicians to predict expulsion of the pregnancy, determine how many women require follow-up evaluation after a telephone interview, and to determine the pregnancy continuation rate after misoprostol and mifepristone in this study.


Recruitment information / eligibility

Status Completed
Enrollment 139
Est. completion date August 2009
Est. primary completion date June 2009
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria:

- healthy females

- requesting an elective termination of pregnancy by medical abortion

- an intrauterine pregnancy </= 63 days gestation

- willing and able to sign the informed consent

- willing to comply with the study protocol and visit schedule

- willing to have a surgical abortion/D&C if indicated

- with easy and ready access to a telephone

Exclusion Criteria:

- contraindication to mifepristone

- contraindication to misoprostol

- cardiovascular disease -hemoglobin <10 g/dL

- known clotting defect or receiving anticoagulants

- pregnancy with an IUD

- breastfeeding

- ultrasound evidence of an early pregnancy failure

- pelvic examination with evidence of acute cervicitis

- prior participation in this research study

- current participation in a conflicting research study

Study Design

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Other:
telephone follow-up
subjects undergoing medical abortion will recieve a telephone call and be asked a series of clinical questions. Expulsion of the pregnancy will be assessed based on the answers to those questions.

Locations

Country Name City State
United States Center for Family Planning Research, Magee-Womens Hospital, University of Pittsburgh Medical Center Pittsburgh Pennsylvania

Sponsors (1)

Lead Sponsor Collaborator
University of Pittsburgh

Country where clinical trial is conducted

United States, 

References & Publications (1)

Rossi B, Creinin MD, Meyn LA. Ability of the clinician and patient to predict the outcome of mifepristone and misoprostol medical abortion. Contraception. 2004 Oct;70(4):313-7. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary To determine the rate of completion of telephone interviews after medical abortion, and the rate of return for follow-up if necessary. four months No
Secondary To determine if a standardized set of questions can predict pregnancy expulsion, and to determine which method of misoprostol administration women prefer. four months No
See also
  Status Clinical Trial Phase
Not yet recruiting NCT02208596 - The Feasibility of Different Doses of Etomidate Admixed With Propofol in Induced Abortion: A Randomized, Double Blind Controlled Trial Phase 4
Completed NCT02412618 - Same-Day Mifepristone-Misoprostol Compared to Misoprostol Only for Surgical Abortion Cervical Preparation Phase 4
Completed NCT01842100 - To Compare the Strategies of Universal Antibiotic Prophylaxis Versus Screen-and-treat in Reducing Infective Complications and Re-infection in Women Who Undergo Termination of Pregnancy N/A
Completed NCT00540748 - Is Oxytocin Given During Surgical Procedure for Abortion Before 12 Weeks of Pregnancy Useful? N/A
Completed NCT03727308 - Study of Clinic-based Versus Self-use of Medical Abortion Pills
Completed NCT00482209 - Study of 400mcg Versus 800mcg Buccal Misoprostol Following Mifepristone 200mg for Abortion up to 63 Days Gestation N/A
Recruiting NCT04242212 - Study of Clinic-based vs. Self-use of a Misoprostol-only Regimen for Induced Abortion
Completed NCT00621543 - Insertion of an Intrauterine Device (IUD) After Medical Abortion N/A
Recruiting NCT01636063 - Mifepristone Versus Misoprostol for Cervical Preparation Prior to Surgical Abortion Between 11 to 15 Weeks N/A
Completed NCT01173003 - Expansion Study of a Simplified Regimen of Medical Abortion Thru 63 Last Menstrual Period (LMP) in Tunisia N/A
Completed NCT05532085 - Assessment of Pain During an Abortion With Knowledge of the Predictive Factors of Pain.
Terminated NCT01776957 - Post Abortion IUD & Recurrent Abortion 2005-2006
Completed NCT01047748 - A Trial of Digoxin Before Second-Trimester Abortion N/A
Completed NCT00401440 - Comparison of Two Regimens of Misoprostol for Second Trimester Medical Termination of Pregnancy Phase 4
Completed NCT00324519 - Randomized Trial Comparing Misoprostol and Foley Bulb for Pregnancy Termination in the Second Trimester Phase 4
Completed NCT04181541 - Midlevel Versus Physician-provided Medical Abortion in the Second Trimester N/A
Completed NCT00286208 - Study of Sublingual Versus Oral Misoprostol Administration Following Mifepristone 200 mg for Abortion up to 63 Days Gestation N/A
Completed NCT01085825 - Study of the Sensitivity of Manual vs Electric Aspiration to Detect Completed Early Abortion N/A